{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T11:06:06Z","timestamp":1788519966864,"version":"build-2803163510"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,5,8]],"date-time":"2019-05-08T00:00:00Z","timestamp":1557273600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,5,8]],"date-time":"2019-05-08T00:00:00Z","timestamp":1557273600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["AOD16024-001-00000\/A120-B.P2016-02"],"award-info":[{"award-number":["AOD16024-001-00000\/A120-B.P2016-02"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurotox Res"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1007\/s12640-019-00034-w","type":"journal-article","created":{"date-parts":[[2019,5,8]],"date-time":"2019-05-08T06:02:46Z","timestamp":1557295366000},"page":"323-333","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["In Vivo Evaluation of A1 Adenosine Agonists as Novel Anticonvulsant Medical Countermeasures to Nerve Agent Intoxication in a Rat Soman Seizure Model"],"prefix":"10.1007","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5817-9846","authenticated-orcid":false,"given":"Thaddeus P.","family":"Thomas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Wegener","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsung-Ming","family":"Shih","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,5,8]]},"reference":[{"issue":"4","key":"34_CR1","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1161\/01.HYP.20.4.457","volume":"20","author":"I Biaggioni","year":"1992","unstructured":"Biaggioni I (1992) Contrasting excitatory and inhibitory effects of adenosine in blood pressure regulation. Hypertension 20(4):457\u2013465","journal-title":"Hypertension"},{"key":"34_CR2","doi-asserted-by":"crossref","unstructured":"Boison D (2012) Adenosine augmentation therapy. In: Noebels JL, Avoli M, Rogawski MA, Olsen RW, Delgado-Escueta AV (eds) Jasper\u2019s basic mechanisms of the epilepsies, 4th edn, Bethesda","DOI":"10.1093\/med\/9780199746545.003.0090"},{"issue":"11","key":"34_CR3","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1007\/s00204-002-0395-x","volume":"76","author":"TJ Bueters","year":"2002","unstructured":"Bueters TJ, Groen B, Danhof M, AP IJ, Van Helden HP (2002) Therapeutic efficacy of the adenosine A1 receptor agonist N6-cyclopentyladenosine (CPA) against organophosphate intoxication. Arch Toxicol 76(11):650\u2013656. \n                    https:\/\/doi.org\/10.1007\/s00204-002-0395-x","journal-title":"Arch Toxicol"},{"issue":"3","key":"34_CR4","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1124\/jpet.102.044644","volume":"304","author":"TJ Bueters","year":"2003","unstructured":"Bueters TJ, Joosen MJ, van Helden HP, Ijzerman AP, Danhof M (2003) Adenosine A1 receptor agonist N6-cyclopentyladenosine affects the inactivation of acetylcholinesterase in blood and brain by sarin. J Pharmacol Exp Ther 304(3):1307\u20131313. \n                    https:\/\/doi.org\/10.1124\/jpet.102.044644","journal-title":"J Pharmacol Exp Ther"},{"key":"34_CR5","unstructured":"Compton JR (2004) Adenosine receptor agonist Pd 81,723 protects against seizure\/status epilepticus and neuropathology following organophosphate exposure. Walter reed army inst of research silver spring md published by wrair and available through dtic"},{"issue":"6","key":"34_CR6","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1111\/j.1476-5381.1996.tb15561.x","volume":"118","author":"AK Dixon","year":"1996","unstructured":"Dixon AK, Gubitz AK, Sirinathsinghji DJ, Richardson PJ, Freeman TC (1996) Tissue distribution of adenosine receptor mRNAs in the rat. Br J Pharmacol 118(6):1461\u20131468","journal-title":"Br J Pharmacol"},{"issue":"1","key":"34_CR7","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1146\/annurev.neuro.24.1.31","volume":"24","author":"TV Dunwiddie","year":"2001","unstructured":"Dunwiddie TV, Masino SA (2001) The role and regulation of adenosine in the central nervous system. Annu Rev Neurosci 24(1):31\u201355. \n                    https:\/\/doi.org\/10.1146\/annurev.neuro.24.1.31","journal-title":"Annu Rev Neurosci"},{"issue":"7","key":"34_CR8","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1046\/j.1528-1157.2003.03603.x","volume":"44","author":"N Gouder","year":"2003","unstructured":"Gouder N, Fritschy JM, Boison D (2003) Seizure suppression by adenosine A1 receptor activation in a mouse model of pharmacoresistant epilepsy. Epilepsia 44(7):877\u2013885","journal-title":"Epilepsia"},{"issue":"3","key":"34_CR9","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/S0304-3940(02)00684-5","volume":"329","author":"A Huber","year":"2002","unstructured":"Huber A, Guttinger M, Mohler H, Boison D (2002) Seizure suppression by adenosine A(2A) receptor activation in a rat model of audiogenic brainstem epilepsy. Neurosci Lett 329(3):289\u2013292","journal-title":"Neurosci Lett"},{"issue":"12","key":"34_CR10","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1164\/rccm.201406-1150CI","volume":"190","author":"EJ Hulse","year":"2014","unstructured":"Hulse EJ, Davies JOJ, Simpson AJ, Sciuto AM, Eddleston M (2014) Respiratory complications of organophosphorus nerve agent and insecticide poisoning. Implications for respiratory and critical care. Am J Respir Crit Care Med 190(12):1342\u20131354. \n                    https:\/\/doi.org\/10.1164\/rccm.201406-1150CI","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"34_CR11","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1007\/s00204-003-0513-4","volume":"78","author":"MA Joosen","year":"2004","unstructured":"Joosen MA, Bueters TH, Helden HM (2004) Cardiovascular effects of the adenosine A1 receptor agonist N6-cyclopentyladenosine (CPA) decisive for its therapeutic efficacy in sarin poisoning. Arch Toxicol 78(1):34\u201339. \n                    https:\/\/doi.org\/10.1007\/s00204-003-0513-4","journal-title":"Arch Toxicol"},{"issue":"10","key":"34_CR12","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1023\/A:1025618324593","volume":"28","author":"JO Malva","year":"2003","unstructured":"Malva JO, Silva AP, Cunha RA (2003) Presynaptic modulation controlling neuronal excitability and epileptogenesis: role of kainate, adenosine and neuropeptide Y receptors. Neurochem Res 28(10):1501\u20131515. \n                    https:\/\/doi.org\/10.1023\/a:1025618324593","journal-title":"Neurochem Res"},{"issue":"3","key":"34_CR13","doi-asserted-by":"publisher","first-page":"145","DOI":"10.2165\/00139709-200423030-00002","volume":"23","author":"TC Marrs","year":"2004","unstructured":"Marrs TC (2004) The role of diazepam in the treatment of nerve agent poisoning in a civilian population. Toxicol Rev 23(3):145\u2013157","journal-title":"Toxicol Rev"},{"issue":"1","key":"34_CR14","first-page":"123","volume":"16","author":"JH McDonough Jr","year":"1995","unstructured":"McDonough JH Jr, Dochterman LW, Smith CD, Shih TM (1995) Protection against nerve agent-induced neuropathology, but not cardiac pathology, is associated with the anticonvulsant action of drug treatment. Neurotoxicology 16(1):123\u2013132","journal-title":"Neurotoxicology"},{"issue":"3","key":"34_CR15","doi-asserted-by":"publisher","first-page":"279","DOI":"10.3109\/01480540903483417","volume":"33","author":"JH McDonough","year":"2010","unstructured":"McDonough JH, McMonagle JD, Shih TM (2010) Time-dependent reduction in the anticonvulsant effectiveness of diazepam against soman-induced seizures in guinea pigs. Drug Chem Toxicol 33(3):279\u2013283. \n                    https:\/\/doi.org\/10.3109\/01480540903483417","journal-title":"Drug Chem Toxicol"},{"issue":"6","key":"34_CR16","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/S0301-0082(02)00155-7","volume":"68","author":"JA Ribeiro","year":"2002","unstructured":"Ribeiro JA, Sebastiao AM, de Mendonca A (2002) Adenosine receptors in the nervous system: pathophysiological implications. Prog Neurobiol 68(6):377\u2013392","journal-title":"Prog Neurobiol"},{"issue":"5","key":"34_CR17","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1038\/sj.bjp.0706043","volume":"144","author":"CW Schindler","year":"2005","unstructured":"Schindler CW, Karcz-Kubicha M, Thorndike EB, M\u00fcller CE, Tella SR, Ferr\u00e9 S, Goldberg SR (2005) Role of central and peripheral adenosine receptors in the cardiovascular responses to intraperitoneal injections of adenosine A1 and A2A subtype receptor agonists. Br J Pharmacol 144(5):642\u2013650. \n                    https:\/\/doi.org\/10.1038\/sj.bjp.0706043","journal-title":"Br J Pharmacol"},{"issue":"2","key":"34_CR18","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/0920-1211(90)90095-D","volume":"7","author":"TM Shih","year":"1990","unstructured":"Shih TM (1990) Anticonvulsant effects of diazepam and MK-801 in soman poisoning. Epilepsy Res 7(2):105\u2013116","journal-title":"Epilepsy Res"},{"issue":"3","key":"34_CR19","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/S0149-7634(05)80028-4","volume":"15","author":"TM Shih","year":"1991","unstructured":"Shih TM, Koviak TA, Capacio BR (1991) Anticonvulsants for poisoning by the organophosphorus compound soman: pharmacological mechanisms. Neurosci Biobehav Rev 15(3):349\u2013362","journal-title":"Neurosci Biobehav Rev"},{"issue":"1","key":"34_CR20","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1002\/jcp.21579","volume":"218","author":"C St Hilaire","year":"2009","unstructured":"St Hilaire C, Carroll SH, Chen H, Ravid K (2009) Mechanisms of induction of adenosine receptor genes and its functional significance. J Cell Physiol 218(1):35\u201344. \n                    https:\/\/doi.org\/10.1002\/jcp.21579","journal-title":"J Cell Physiol"},{"issue":"6","key":"34_CR21","doi-asserted-by":"publisher","first-page":"385","DOI":"10.3109\/15376516.2014.920450","volume":"24","author":"TP Thomas","year":"2014","unstructured":"Thomas TP, Shih T-M (2014) Stimulation of central A1 adenosine receptors suppresses seizure and neuropathology in a soman nerve agent seizure rat model. Toxicol Mech Methods 24(6):385\u2013395. \n                    https:\/\/doi.org\/10.3109\/15376516.2014.920450","journal-title":"Toxicol Mech Methods"},{"key":"34_CR22","doi-asserted-by":"publisher","first-page":"171","DOI":"10.3109\/01480549809007409","volume":"21","author":"HP van Helden","year":"1998","unstructured":"van Helden HP, Groen B, Moor E, Westerink BH, Bruijnzeel PL (1998) New generic approach to the treatment of organophosphate poisoning: adenosine receptor mediated inhibition of ACh-release. Drug Chem Toxicol 21 Suppl 1(s1):171\u2013181. \n                    https:\/\/doi.org\/10.3109\/01480549809007409","journal-title":"Drug Chem Toxicol"},{"issue":"1","key":"34_CR23","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1002\/jcp.20138","volume":"202","author":"R Yaar","year":"2005","unstructured":"Yaar R, Jones MR, Chen JF, Ravid K (2005) Animal models for the study of adenosine receptor function. J Cell Physiol 202(1):9\u201320. \n                    https:\/\/doi.org\/10.1002\/jcp.20138","journal-title":"J Cell Physiol"},{"issue":"2","key":"34_CR24","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/0306-4522(94)90032-9","volume":"58","author":"D Young","year":"1994","unstructured":"Young D, Dragunow M (1994) Status epilepticus may be caused by loss of adenosine anticonvulsant mechanisms. Neuroscience 58(2):245\u2013261","journal-title":"Neuroscience"}],"container-title":["Neurotoxicity Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12640-019-00034-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12640-019-00034-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12640-019-00034-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,17]],"date-time":"2020-05-17T17:23:33Z","timestamp":1589736213000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12640-019-00034-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,8]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["34"],"URL":"https:\/\/doi.org\/10.1007\/s12640-019-00034-w","relation":{},"ISSN":["1029-8428","1476-3524"],"issn-type":[{"value":"1029-8428","type":"print"},{"value":"1476-3524","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,8]]},"assertion":[{"value":"18 September 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 March 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The views expressed in this report are those of the author(s) and do not reflect the official policy of the Department of Army, Department of Defense, or the U.S. Government. The experimental protocol was approved by the Institutional Animal Care and Use Committee at the U.S. Army Medical Research Institute of Chemical Defense, and all procedures were conducted in accordance with the principles stated in the Guide for the Care and Use of Laboratory Animals and the Animal Welfare Act of 1966 (P.L. 89-544), as amended. The facility where this research was conducted is fully accredited by the Association for Assessment and Accreditation of Laboratory Animal Care International. The use of trade names does not constitute an official endorsement or approval of the use of such commercial hardware or software. This document may not be cited for purposes of advertisement.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclaimers"}}]}}